Vesselon
Manufacturing · Connecticut, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
101 Merritt 7, Norwalk, Connecticut, 068...Phone Number
(203) 989-0500Website
www.vesselon.comRevenue
<$5 MillionIndustry
About Vesselon
Vesselon specializes in developing patentable drug co-formulations that enhance the efficacy of therapeutic drugs through the use of FDA-approved lipid microspheres and self-assembling liposomes. Their innovative platform allows drug firms to extend the lifecycle of existing drugs, grow market share, and enable new indications without altering the original drug formulation. With a focus on improving drug delivery and reducing side effects, Vesselon aims to revolutionize drug development and lifecycle management. Their technology is supported by extensive preclinical trials and a low-risk regulatory path, making it an attractive option for pharmaceutical companies.Explore more
Vesselon Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Vesselon
Compare insights from companies similar to Vesselon, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Vesselon Tech Stack
A closer look at the technologies used by Vesselon
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vesselon
Sign Up For FreeTo access detailed company insights
Vesselon specializes in developing patentable drug co-formulations that enhance the efficacy of therapeutic drugs through the use of FDA-approved lipid microspheres and self-assembling liposomes. Their innovative platform allows drug firms to extend the lifecycle of existing drugs, grow market share, and enable new indications without altering the... Read More
